Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Mol Cancer Ther. 2009 Oct;8(10):2872–2881. doi: 10.1158/1535-7163.MCT-09-0583

Figure 1. Evaluation of viable CEP levels in mice treated with metronomic cyclophosphamide (CTX), OXi-4503 (OXi) or a combination of both drugs.

Figure 1

Non-tumor bearing nude mice (n=5 per group) were treated with LDM cyclophosphamide (CTX). and OXi-4503. Untreated mice and mice treated with either of the drugs alone were used as controls. 4 hours after OXi-4503 administration, blood was drawn for the evaluation of viable CEPs using five color flow cytometry. Error bars + SD; * 0.01 < p < 0.05; ** p < 0.01 using student’s t-test unpaired. Values are compared to control mice, unless indicated otherwise.